Niagen Bioscience宣布与Olympia Pharmaceuticals达成合作,后者正式加入其503B复合药物合作伙伴网络,共同推进明星产品Niagen Plus™的市场布局。
Niagen Bioscience宣布与Olympia Pharmaceuticals达成合作,后者正式加入其503B复合药物合作伙伴网络,共同推进明星产品Niagen Plus™的市场布局。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.